A systematic comparison of kinetic modelling methods generating parametric maps for [11C]-(R)-PK11195

NeuroImage

Volumn 36, Issue 1, 2007, Pages 28-37

  Anderson, Alexander N ^a   Pavese, Nicola ^b   Edison, Paul ^a,b   Tai, Yan F ^a,b   Hammers, Alexander ^a,b   Gerhard, Alexander ^b,c   Brooks, David J ^a,b   Turkheimer, Federico E ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

DEPICT; Kinetic modelling; Logan plot; Microglia; PET; pk11195; Wavelets

Indexed keywords

CARBON 11; CESIUM 137; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; TRACER; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUNTINGTON CHOREA; IMMUNOCOMPETENT CELL; KINETICS; MICROGLIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETRIC TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCORING SYSTEM;

ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; CARBON RADIOISOTOPES; CLUSTER ANALYSIS; COMPUTER GRAPHICS; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOQUINOLINES; MATHEMATICAL COMPUTING; MICROGLIA; PHARMACOKINETICS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, GABA-A; SENSITIVITY AND SPECIFICITY;

EID: 34247225480     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.02.017     Document Type: Article

References (45)

1. Alpert N.M., Reilhac A., Chio T.C., and Selesnick I. Optimization of dynamic measurement of receptor kinetics by wavelet denoising. NeuroImage 30 (2006) 444-451
2. Aston J.A., Gunn R.N., Hinz R., and Turkheimer F.E. Wavelet variance components in image space for spatiotemporal neuroimaging data. NeuroImage 25 (2005) 159-168
3. Banati R.B. Visualising microglial activation in vivo. Glia 40 (2002) 206-217
4. Bertoldo A., Pietra L., Moresco R.M., Panzacchi A., Gilardi M.C., Matarrese M., Turolla E., Fazio F., and Cobelli C. Quantitative in vivo imaging of microglia activation using [11C]PK11195 and two reference tissue models. NeuroImage 31 (2006) T79
5. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., and Banati R.B. In-vivo measurement of activated microglia in dementia. Lancet 358 (2001) 461-467
6. Charbonneau P., Syrota A., Crouzel C., Valois J.M., Prenant C., and Crouzel M. Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation 73 (1986) 476-483
7. Choi H.B., Khoo C., Ryu J.K., van B.E., Kim S.U., and McLarnon J.G. Inhibition of lipopolysaccharide-induced cyclooxygenase-2, tumor necrosis factor-alpha and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195. J. Neurochem. 83 (2002) 546-555
8. Cselenyi Z., Olsson H., Halldin C., Gulyas B., and Farde L. A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635. NeuroImage 32 (2006) 1690-1708
9. Debruyne J.C., Van Laere K.J., Versijpt J., De Vos F., Eng J.K., Strijckmans K., Santens P., Achten E., Slegers G., Korf J., Dierckx R.A., and De Reuck J.L. Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients. Acta Neurol. Belg. 102 (2002) 127-135
10. Debruyne J.C., Versijpt J., Van Laere K.J., De Vos F., Keppens J., Strijckmans K., Achten E., Slegers G., Dierckx R.A., Korf J., and De Reuck J.L. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur. J. Neurol. 10 (2003) 257-264
11. Frankle W.G., Slifstein M., Gunn R.N., Huang Y., Hwang D.R., Darr E.A., Narendran R., bi-Dargham A., and Laruelle M. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. J. Nucl. Med. 47 (2006) 815-826
12. Gebicke-Haerter P.J. Microarrays and expression profiling in microglia research and in inflammatory brain disorders. J. Neurosci. Res. 81 (2005) 327-341
13. Gerhard A., Banati R.B., Goerres G.B., Cagnin A., Myers R., Gunn R.N., Turkheimer F., Good C.D., Mathias C.J., Quinn N., Schwarz J., and Brooks D.J. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61 (2003) 686-689
14. Gerhard A., Watts J., Trender-Gerhard I., Turkheimer F., Banati R.B., Bhatia K., and Brooks D.J. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration. Mov. Disord. 19 (2004) 1221-1226
15. Gerhard A., Schwarz J., Myers R., Wise R., and Banati R.B. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. NeuroImage 24 (2005) 591-595
16. Gerhard A., Pavese N., Hotton G., Turkheimer F., Es M., Hammers A., Eggert K., Oertel W., Banati R.B., and Brooks D.J. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol. Dis. 21 (2006) 404-412
17. Gerhard A., Trender-Gerhard I., Turkheimer F., Quinn N.P., Bhatia K.P., and Brooks D.J. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy. Mov. Disord. 21 (2006) 89-93
18. Gunn R.N., Lammertsma A.A., Hume S.P., and Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage 6 (1997) 279-287
19. Gunn R.N., Gunn S.R., and Cunningham V.J. Positron emission tomography compartmental models. J. Cereb. Blood Flow Metab. 21 (2001) 635-652
20. Gunn R.N., Gunn S.R., Turkheimer F.E., Aston J.A., and Cunningham V.J. Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling. J. Cereb. Blood Flow Metab. 22 (2002) 1425-1439
21. Hammers A., Allom R., Koepp M.J., Free S.L., Myers R., Lemieux L., Mitchell T.N., Brooks D.J., and Duncan J.S. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp. 19 (2003) 224-247
22. Hammoud D.A., Endres C.J., Chander A.R., Guilarte T.R., Wong D.F., Sacktor N.C., McArthur J.C., and Pomper M.G. Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS. J. NeuroVirol. 11 (2005) 346-355
23. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
24. Kropholler M.A., Boellaard R., Schuitemaker A., van Berckel B.N., Luurtsema G., Windhorst A.D., and Lammertsma A.A. Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies. J. Cereb. Blood Flow Metab. 25 (2005) 842-851
25. Kropholler M.A., Boellaard R., Schuitemaker A., Folkersma H., Bart N., van Berckel B.N., and Lammertsma A.A. Evaluation of reference tissue models for the analysis of [11C](R)-PK11195 studies. J. Cereb. Blood Flow Metab. 26 (2006) 1431-1441
26. Kukreja S.L., and Gunn R.N. Bootstrapped DEPICT for error estimation in PET functional imaging. NeuroImage 21 (2004) 1096-1104
27. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., and Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 16 (1996) 834-840
28. Papadopoulos V., and Brown A.S. Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis. J. Steroid Biochem. Mol. Biol. 53 (1995) 103-110
29. Parsey R.V., Slifstein M., Hwang D.R., bi-Dargham A., Simpson N., Mawlawi O., Guo N.N., Van H.R., Mann J.J., and Laruelle M. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions. J. Cereb. Blood Flow Metab. 20 (2000) 1111-1133
30. Pavese N., Gerhard A., Tai Y.F., Ho A.K., Turkheimer F., Barker R.A., Brooks D.J., and Piccini P. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66 (2006) 1638-1643
31. Ryu J.K., Choi H.B., and McLarnon J.G. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum. Neurobiol. Dis. 20 (2005) 550-561
32. Sapp E., Kegel K.B., Aronin N., Hashikawa T., Uchiyama Y., Tohyama K., Bhide P.G., Vonsattel J.P., and DiFiglia M. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 60 (2001) 161-172
33. Schumacher M., Guennoun R., Robert F., Carelli C., Gago N., Ghoumari A., Gonzalez Deniselle M.C., Gonzalez S.L., Ibanez C., Labombarda F., Coirini H., Baulieu E.E., and De Nicola A.F. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm. IGF Res. 14 Suppl. A (2004) S18-S33
34. Schwartz M., Butovsky O., Bruck W., and Hanisch U.K. Microglial phenotype: is the commitment reversible?. Trends Neurosci. 29 (2006) 68-74
35. Shah F., Hume S.P., Pike V.W., Ashworth S., and McDermott J. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl. Med. Biol. 21 (1994) 573-581
36. Shrout P., and Fleiss J. Intraclass correlations: uses in assessing rater reliability. Psychol. Bull. 2 (1979) 420-428
37. Spinks T.J., Miller M.P., Bailey D.L., Bloomfield P.M., Livieratos L., and Jones T. The effect of activity outside the direct field of view in a 3D-only whole-body positron tomograph. Phys. Med. Biol. 43 (1998) 895-904
38. Spinks T.J., Jones T., Bloomfield P.M., Bailey D.L., Miller M., Hogg D., Jones W.F., Vaigneur K., Reed J., Young J., Newport D., Moyers C., Casey M.E., and Nutt R. Physical characteristics of the ECAT EXACT3D positron tomograph. Phys. Med. Biol. 45 (2000) 2601-2618
39. Turkheimer F.E., Aston J.A., Banati R.B., Riddell C., and Cunningham V.J. A linear wavelet filter for parametric imaging with dynamic PET. IEEE Trans. Med. Imaging 22 (2003) 289-301
40. Turkheimer F.E., Edison P., Pavese N., Roncaroli F., Anderson A.N., Hammers A., Gerhard A., Hinz R., Tai Y.F., and Brooks D.J. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J. Nucl. Med. 48 (2007) 158-167
41. Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C., Shaw C.E., Brooks D.J., Leigh P.N., and Banati R.B. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 15 (2004) 601-609
42. Turner M.R., Gerhard A., Al-Chalabi A., Shaw C.E., Hughes R.A., Banati R.B., Brooks D.J., and Leigh P.N. Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET. J. Neurol., Neurosurg. Psychiatry 76 (2005) 871-874
43. Veenman L., and Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol. Ther. 110 (2006) 503-524
44. Versijpt J.J., Dumont F., Van Laere K.J., Decoo D., Santens P., Audenaert K., Achten E., Slegers G., Dierckx R.A., and Korf J. Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study. Eur. Neurol. 50 (2003) 39-47
45. Ziolko S.K., Weissfeld L.A., Klunk W.E., Mathis C.A., Hoge J.A., Lopresti B.J., DeKosky S.T., and Price J.C. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease. NeuroImage 33 (2006) 94-102